Fluorine in PDB 8u0q: Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series
Enzymatic activity of Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series
All present enzymatic activity of Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series:
1.8.1.4;
Protein crystallography data
The structure of Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series, PDB code: 8u0q
was solved by
A.A.Dementiev,
M.Michino,
J.Vendome,
J.Ginn,
R.Bryk,
A.Olland,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
45.53 /
1.69
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
83.335,
97.928,
123.806,
90,
90,
90
|
R / Rfree (%)
|
17.1 /
20.8
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series
(pdb code 8u0q). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series, PDB code: 8u0q:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 8u0q
Go back to
Fluorine Binding Sites List in 8u0q
Fluorine binding site 1 out
of 4 in the Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F502
b:47.3
occ:1.00
|
F26
|
A:U4I502
|
0.0
|
47.3
|
1.0
|
C25
|
A:U4I502
|
1.4
|
39.9
|
1.0
|
F27
|
A:U4I502
|
2.2
|
45.0
|
1.0
|
C24
|
A:U4I502
|
2.3
|
30.6
|
1.0
|
C28
|
A:U4I502
|
2.9
|
27.0
|
1.0
|
CB
|
A:GLU448
|
3.3
|
25.8
|
1.0
|
C23
|
A:U4I502
|
3.4
|
30.3
|
1.0
|
CD
|
A:GLU448
|
3.5
|
33.5
|
1.0
|
OE2
|
A:GLU448
|
3.5
|
33.2
|
1.0
|
O
|
A:HOH633
|
3.5
|
41.3
|
1.0
|
ND2
|
A:ASN382
|
3.7
|
29.6
|
1.0
|
OE1
|
A:GLU448
|
3.7
|
31.4
|
1.0
|
CA
|
A:ASN382
|
4.0
|
24.2
|
1.0
|
CG
|
A:GLU448
|
4.0
|
23.8
|
1.0
|
O
|
A:ALA381
|
4.1
|
28.7
|
1.0
|
C19
|
A:U4I502
|
4.1
|
27.2
|
1.0
|
CG
|
A:ASN382
|
4.2
|
31.9
|
1.0
|
N
|
A:ALA383
|
4.2
|
26.3
|
1.0
|
CB
|
A:ASN382
|
4.5
|
22.2
|
1.0
|
C21
|
A:U4I502
|
4.6
|
33.0
|
1.0
|
CA
|
A:GLU448
|
4.6
|
24.7
|
1.0
|
C
|
A:GLU448
|
4.7
|
27.7
|
1.0
|
CZ
|
A:PHE377
|
4.7
|
29.6
|
1.0
|
C
|
A:ASN382
|
4.7
|
23.2
|
1.0
|
O
|
A:HOH616
|
4.8
|
36.6
|
1.0
|
C20
|
A:U4I502
|
4.9
|
30.1
|
1.0
|
CE2
|
A:PHE377
|
4.9
|
31.4
|
1.0
|
O
|
A:GLU448
|
4.9
|
25.7
|
1.0
|
N
|
A:ALA449
|
5.0
|
22.2
|
1.0
|
C
|
A:ALA381
|
5.0
|
28.1
|
1.0
|
O
|
A:THR445
|
5.0
|
24.4
|
1.0
|
N
|
A:ASN382
|
5.0
|
28.8
|
1.0
|
OD1
|
A:ASN382
|
5.0
|
31.7
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 8u0q
Go back to
Fluorine Binding Sites List in 8u0q
Fluorine binding site 2 out
of 4 in the Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F502
b:45.0
occ:1.00
|
F27
|
A:U4I502
|
0.0
|
45.0
|
1.0
|
C25
|
A:U4I502
|
1.4
|
39.9
|
1.0
|
F26
|
A:U4I502
|
2.2
|
47.3
|
1.0
|
C24
|
A:U4I502
|
2.3
|
30.6
|
1.0
|
C28
|
A:U4I502
|
2.9
|
27.0
|
1.0
|
CB
|
A:ASN463
|
3.2
|
27.4
|
1.0
|
C23
|
A:U4I502
|
3.4
|
30.3
|
1.0
|
ND2
|
A:ASN463
|
3.6
|
31.6
|
1.0
|
CG
|
A:ASN463
|
3.7
|
32.0
|
1.0
|
CG
|
A:GLU452
|
3.7
|
30.5
|
1.0
|
CZ
|
A:PHE377
|
3.8
|
29.6
|
1.0
|
O
|
A:ALA381
|
3.9
|
28.7
|
1.0
|
OE2
|
A:GLU452
|
4.0
|
42.3
|
1.0
|
C19
|
A:U4I502
|
4.2
|
27.2
|
1.0
|
CD
|
A:GLU452
|
4.2
|
41.6
|
1.0
|
O3
|
A:GOL503
|
4.4
|
59.0
|
1.0
|
CE1
|
A:PHE377
|
4.4
|
30.1
|
1.0
|
OD1
|
A:ASN463
|
4.5
|
32.0
|
1.0
|
C21
|
A:U4I502
|
4.5
|
33.0
|
1.0
|
CB
|
A:GLU448
|
4.6
|
25.8
|
1.0
|
CE2
|
A:PHE377
|
4.6
|
31.4
|
1.0
|
CA
|
A:ASN463
|
4.7
|
27.1
|
1.0
|
OE2
|
A:GLU448
|
4.7
|
33.2
|
1.0
|
O
|
A:HOH616
|
4.7
|
36.6
|
1.0
|
C20
|
A:U4I502
|
4.9
|
30.1
|
1.0
|
O
|
A:GLU448
|
4.9
|
25.7
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 8u0q
Go back to
Fluorine Binding Sites List in 8u0q
Fluorine binding site 3 out
of 4 in the Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F523
b:39.6
occ:1.00
|
F26
|
A:U4I523
|
0.0
|
39.6
|
1.0
|
C25
|
A:U4I523
|
1.4
|
29.6
|
1.0
|
F27
|
A:U4I523
|
2.2
|
39.3
|
1.0
|
C24
|
A:U4I523
|
2.3
|
29.5
|
1.0
|
C28
|
A:U4I523
|
2.9
|
25.5
|
1.0
|
CB
|
B:ASN463
|
3.2
|
26.2
|
1.0
|
C23
|
A:U4I523
|
3.4
|
25.3
|
1.0
|
CG
|
B:ASN463
|
3.7
|
36.9
|
1.0
|
ND2
|
B:ASN463
|
3.7
|
32.6
|
1.0
|
CZ
|
B:PHE377
|
3.7
|
29.0
|
1.0
|
CG
|
B:GLU452
|
3.7
|
30.1
|
1.0
|
OE2
|
B:GLU452
|
3.8
|
37.9
|
1.0
|
O
|
B:ALA381
|
3.9
|
25.7
|
1.0
|
C19
|
A:U4I523
|
4.1
|
27.6
|
1.0
|
CD
|
B:GLU452
|
4.1
|
37.5
|
1.0
|
CE2
|
B:PHE377
|
4.3
|
28.2
|
1.0
|
CB
|
B:GLU448
|
4.5
|
24.2
|
1.0
|
OE2
|
B:GLU448
|
4.6
|
29.6
|
1.0
|
C21
|
A:U4I523
|
4.6
|
25.7
|
1.0
|
OD1
|
B:ASN463
|
4.6
|
31.2
|
1.0
|
CE1
|
B:PHE377
|
4.6
|
25.2
|
1.0
|
CA
|
B:ASN463
|
4.7
|
27.1
|
1.0
|
O
|
B:HOH614
|
4.7
|
33.4
|
1.0
|
C20
|
A:U4I523
|
4.9
|
27.5
|
1.0
|
O
|
B:GLU448
|
4.9
|
27.1
|
1.0
|
CD
|
B:GLU448
|
5.0
|
33.6
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 8u0q
Go back to
Fluorine Binding Sites List in 8u0q
Fluorine binding site 4 out
of 4 in the Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Co-Crystal Structure of Optimized Analog Tdi-13537 Provided New Insights Into the Potency Determinants of the Sulfonamide Inhibitor Series within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F523
b:39.3
occ:1.00
|
F27
|
A:U4I523
|
0.0
|
39.3
|
1.0
|
C25
|
A:U4I523
|
1.4
|
29.6
|
1.0
|
F26
|
A:U4I523
|
2.2
|
39.6
|
1.0
|
C24
|
A:U4I523
|
2.4
|
29.5
|
1.0
|
C28
|
A:U4I523
|
2.8
|
25.5
|
1.0
|
O
|
B:HOH606
|
3.1
|
42.9
|
1.0
|
CB
|
B:GLU448
|
3.4
|
24.2
|
1.0
|
C23
|
A:U4I523
|
3.5
|
25.3
|
1.0
|
ND2
|
B:ASN382
|
3.5
|
28.6
|
1.0
|
OE2
|
B:GLU448
|
3.5
|
29.6
|
1.0
|
CD
|
B:GLU448
|
3.5
|
33.6
|
1.0
|
OE1
|
B:GLU448
|
3.7
|
31.6
|
1.0
|
CA
|
B:ASN382
|
3.9
|
21.9
|
1.0
|
O
|
B:ALA381
|
4.0
|
25.7
|
1.0
|
C19
|
A:U4I523
|
4.1
|
27.6
|
1.0
|
CG
|
B:GLU448
|
4.1
|
24.2
|
1.0
|
CG
|
B:ASN382
|
4.1
|
27.7
|
1.0
|
N
|
B:ALA383
|
4.1
|
25.2
|
1.0
|
CB
|
B:ASN382
|
4.4
|
21.6
|
1.0
|
CZ
|
B:PHE377
|
4.6
|
29.0
|
1.0
|
C
|
B:ASN382
|
4.6
|
25.8
|
1.0
|
C21
|
A:U4I523
|
4.6
|
25.7
|
1.0
|
CA
|
B:GLU448
|
4.7
|
22.5
|
1.0
|
C
|
B:GLU448
|
4.7
|
25.7
|
1.0
|
O
|
B:HOH614
|
4.8
|
33.4
|
1.0
|
C20
|
A:U4I523
|
4.9
|
27.5
|
1.0
|
N
|
B:ASN382
|
4.9
|
24.9
|
1.0
|
C
|
B:ALA381
|
4.9
|
26.1
|
1.0
|
OD1
|
B:ASN382
|
4.9
|
26.6
|
1.0
|
O
|
B:THR445
|
4.9
|
22.4
|
1.0
|
CE1
|
B:PHE377
|
4.9
|
25.2
|
1.0
|
O
|
B:GLU448
|
5.0
|
27.1
|
1.0
|
|
Reference:
M.Michino,
A.Beautrait,
N.A.Boyles,
A.Nadupalli,
A.Dementiev,
S.Sun,
J.Ginn,
L.Baxt,
R.Suto,
R.Bryk,
S.V.Jerome,
D.J.Huggins,
J.Vendome.
Shape-Based Virtual Screening of A Billion-Compound Library Identifies Mycobacterial Lipoamide Dehydrogenase Inhibitors. Acs Bio Med Chem Au V. 3 507 2023.
ISSN: ESSN 2694-2437
PubMed: 38144256
DOI: 10.1021/ACSBIOMEDCHEMAU.3C00046
Page generated: Sat Aug 3 00:46:04 2024
|